CYTEK BIOSCIENCES, INC. Deferred Income Tax Expense (Benefit)
CYTEK BIOSCIENCES, INC. (CTKB) reported Deferred Income Tax Expense (Benefit) of -$183.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-08-05
- CYTEK BIOSCIENCES, INC. deferred income tax expense (benefit) for the quarter ending 2026-06-30 was $0.00.
- CYTEK BIOSCIENCES, INC. deferred income tax expense (benefit) for the quarter ending 2026-03-31 was -$183.00K.
- CYTEK BIOSCIENCES, INC. deferred income tax expense (benefit) for the quarter ending 2025-12-31 was $38.58M.
- CYTEK BIOSCIENCES, INC. deferred income tax expense (benefit) for the quarter ending 2025-09-30 was -$2.63M.
- CYTEK BIOSCIENCES, INC. deferred income tax expense (benefit) for fiscal 2025 was $33.56M.
- CYTEK BIOSCIENCES, INC. deferred income tax expense (benefit) for fiscal 2024 was -$2.89M.
- CYTEK BIOSCIENCES, INC. deferred income tax expense (benefit) for fiscal 2023 was $0.00.
- CYTEK BIOSCIENCES, INC. deferred income tax expense (benefit) for fiscal 2022 was $0.00.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$183.00K 10-Q · filed 2026-08-05 | $38.39M derived: sum of 3 quarters · filed 2026-08-05 | $35.77M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | -$183.00K 10-Q · filed 2026-05-07 | $38.39M derived: sum of 2 quarters · filed 2026-05-07 | $35.77M derived: sum of 3 quarters · filed 2026-05-07 | $33.71M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $38.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $35.95M derived: sum of 2 quarters · filed 2026-02-26 | $33.89M derived: sum of 3 quarters · filed 2026-08-05 | $33.56M 10-K · filed 2026-02-26 | |
| 2025-09-30 | -$2.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$4.68M derived: sum of 2 quarters · filed 2026-08-05 | -$5.02M 10-Q · filed 2025-11-05 | -$7.91M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | -$2.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$2.39M 10-Q · filed 2026-08-05 | -$5.28M derived: sum of 3 quarters · filed 2026-08-05 | -$5.28M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | -$336.00K 10-Q · filed 2026-05-07 | -$3.22M derived: sum of 2 quarters · filed 2026-05-07 | -$3.22M derived: sum of 3 quarters · filed 2026-05-07 | -$3.22M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | -$2.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$2.89M derived: sum of 2 quarters · filed 2026-02-26 | -$2.89M derived: sum of 3 quarters · filed 2026-02-26 | -$2.89M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $0.00 10-Q · filed 2025-08-06 | |||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 | ||||
| 2023-12-31 | $0.00 10-K · filed 2026-02-26 | -$10.03M 10-K · filed 2024-03-13 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-28 | -$11.29M 10-K · filed 2023-03-01 | |||
| 2021-12-31 | -$1.80M 10-K · filed 2024-03-13 | ||||
| 2020-12-31 | -$7.38M 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |